Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
753.41
+23.68 (3.25%)
At close: Nov 20, 2024, 4:00 PM
750.24
-3.17 (-0.42%)
Pre-market: Nov 21, 2024, 4:12 AM EST
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $678.39 billion as of November 21, 2024. Its market cap has increased by 20.07% in one year.
Market Cap
678.39B
Enterprise Value
705.63B
1-Year Change
20.07%
Ranking
Category
Stock Price
$753.41
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $678.39B, an increase of 583.54%. That is a compound annual growth rate of 7.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 692.74B | 25.19% |
Dec 29, 2023 | 553.37B | 59.19% |
Dec 30, 2022 | 347.61B | 31.56% |
Dec 31, 2021 | 264.23B | 63.60% |
Dec 31, 2020 | 161.51B | 27.99% |
Dec 31, 2019 | 126.19B | 2.94% |
Dec 31, 2018 | 122.58B | 31.81% |
Dec 29, 2017 | 93.00B | 14.54% |
Dec 30, 2016 | 81.20B | -13.04% |
Dec 31, 2015 | 93.37B | 21.55% |
Dec 31, 2014 | 76.82B | 33.69% |
Dec 31, 2013 | 57.46B | 0.39% |
Dec 31, 2012 | 57.23B | 18.95% |
Dec 30, 2011 | 48.12B | 19.08% |
Dec 31, 2010 | 40.41B | -1.52% |
Dec 31, 2009 | 41.03B | -10.38% |
Dec 31, 2008 | 45.79B | -24.40% |
Dec 31, 2007 | 60.56B | 2.72% |
Dec 29, 2006 | 58.96B | -8.34% |
Dec 30, 2005 | 64.32B | 0.16% |
Dec 31, 2004 | 64.22B | -18.68% |
Dec 31, 2003 | 78.97B | 10.71% |
Dec 31, 2002 | 71.33B | -19.21% |
Dec 31, 2001 | 88.30B | -15.83% |
Dec 29, 2000 | 104.90B | 44.66% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UnitedHealth Group | 542.65B |
Novo Nordisk | 443.39B |
Johnson & Johnson | 372.63B |
AbbVie | 293.84B |
Merck & Co. | 244.26B |
Novartis AG | 205.87B |
Abbott Laboratories | 203.56B |
AstraZeneca | 194.35B |